STOCK TITAN
  1. Home
  2. Financials
  3. DNA
  4. EPS (Diluted)

Ginkgo Bioworks Holdings, Inc. (DNA) EPS by Year

DNA

Ginkgo Bioworks Holdings, Inc. lost $5.64 per diluted share in fiscal year 2025. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Ginkgo Bioworks Holdings, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$5.64
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

DNA EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
EPS (Diluted)-$5.64-$0.01+42.9%-$0.02-$0.05-$1.39-$0.100.0%-$0.10

DNA EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)N/AN/A-$1.42+27.6%-$1.45-34.3%-$1.10-$1.68-$1.96+54.2%-$1.08-$4.23-$3.32-$4.28-$6.21

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Ginkgo Bioworks Holdings, Inc. financials

Frequently Asked Questions

What was Ginkgo Bioworks Holdings, Inc.'s diluted earnings per share in fiscal year 2025?

Ginkgo Bioworks Holdings, Inc. lost $5.64 per diluted share in fiscal year 2025.

How has Ginkgo Bioworks Holdings, Inc.'s diluted earnings per share changed over the years?

Across the 7 fiscal years this page covers, Ginkgo Bioworks Holdings, Inc. (DNA) diluted earnings per share went from -$0.10 in fiscal year 2019 to -$5.64 in fiscal year 2025.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Ginkgo Bioworks Holdings, Inc. (DNA) reported on that line in every period on record.